CELC

Celcuity
CELC

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.12B
EV
$2.05B
Shares Outstanding
56.80M
Beta
0.68

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$69.43
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Celcuity Inc.

gainify
CELC

Celcuity Inc.

CELC

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s CELsignia diagnostic platform uses a patient’s living tumor cells to identify the spec...

Sector

Healthcare

Industry

Biotechnology

CEO

Sullivan, Brian

Employees

87

IPO Date

2017-09-20

Headquarters

16305–36th Avenue North, Suite 100, Minneapolis, Minnesota, 55446, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.